Mizuho Maintains Outperform on BrightSpring Health, Raises Price Target to $42

Benzinga · 2d ago
Mizuho analyst Ann Hynes maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $38 to $42.